BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Elsayad K, Kroeger K, Greve B, Moustakis C, Assaf C, Stadler R, Lenz G, Weishaupt C, Eich HT. Low-dose total skin electron beam therapy: Quality of life improvement and clinical impact of maintenance and adjuvant treatment in patients with mycosis fungoides or Sezary syndrome. Strahlenther Onkol 2020;196:77-84. [PMID: 31591658 DOI: 10.1007/s00066-019-01517-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Elsayad K, Stadler R, Steinbrink K, Eich HT. Combined total skin radiotherapy and immune checkpoint inhibitors: A promising potential treatment for mycosis fungoides and Sezary syndrome. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2020;18:193-7. [DOI: 10.1111/ddg.14044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Aral İP, Göçer Gürok N, Konuk AO, Üçer Ö. Ultra-Low-Dose Radiotherapy for Palliation of Mycosis Fungoides. Case Rep Dermatol Med 2020;2020:4216098. [PMID: 32274222 DOI: 10.1155/2020/4216098] [Reference Citation Analysis]
3 Elsayad K, Stadler R, Steinbrink K, Eich HT. Kombination von Ganzhautbestrahlung und Immuncheckpoint-Inhibitoren: Eine vielversprechende Therapieoption bei Mycosis fungoides und Sézary-Syndrom. J Dtsch Dermatol Ges 2020;18:193-8. [PMID: 32130771 DOI: 10.1111/ddg.14044_g] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Bhat TS, Herbosa CM, Rosenberg AR, Sogade O, Jeffe DB, Mehta-Shah N, Semenov YR, Musiek AC. Current measures are not sufficient: an interview-based qualitative assessment of quality of life in cutaneous T-cell lymphoma. Br J Dermatol 2021;184:310-8. [PMID: 32510571 DOI: 10.1111/bjd.19298] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Flores-Balcázar C, Urías-Arce DM, Charli-Joseph Y, De León-Alfaro MA, Pérez-Álvarez SI, Ramos-Prudencio R. Total skin electron beam therapy for primary cutaneous T-cell lymphomas: clinical characteristics and outcomes in a Mexican reference center. Rep Pract Oncol Radiother 2020;25:562-7. [PMID: 32494229 DOI: 10.1016/j.rpor.2020.03.020] [Reference Citation Analysis]
6 Shariff M, Stillkrieg W, Lotter M, Lohmann D, Weissmann T, Fietkau R, Bert C. Dosimetry, Optimization and FMEA of Total Skin Electron Irradiation (TSEI). Z Med Phys 2021:S0939-3889(21)00086-6. [PMID: 34740500 DOI: 10.1016/j.zemedi.2021.09.004] [Reference Citation Analysis]
7 Rolf D, Elsayad K, Eich HT. Acute and sub-acute toxicity profile of ultra-hypofractionated low-dose total skin electron beam with two 4 Gy fractions for cutaneous T cell lymphoma. J Cancer Res Clin Oncol 2021;147:1757-61. [PMID: 33219856 DOI: 10.1007/s00432-020-03449-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Newman NB, Patel CG, Ding GX, Zic JA, Zwerner J, Osmundson EC, Kirschner AN. Prospective observational trial of low-dose skin electron beam therapy in mycosis fungoides using a rotational technique. J Am Acad Dermatol 2021;85:121-7. [PMID: 33333150 DOI: 10.1016/j.jaad.2020.12.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Dippel E, Assaf C, Becker JC, von Bergwelt-Baildon M, Bernreiter S, Cozzio A, Eich HT, Elsayad K, Follmann M, Grabbe S, Hillen U, Klapper W, Klemke CD, Loquai C, Meiss F, Mitteldorf C, Wehkamp U, Nashan D, Nicolay JP, Oschlies I, Schlaak M, Stranzenbach R, Moritz R, Stoll C, Vag T, Weichenthal M, Wobser M, Stadler R. S2k-Guidelines - Cutaneous lymphomas (ICD10 C82 - C86): Update 2021. J Dtsch Dermatol Ges 2022;20:537-54. [PMID: 35446497 DOI: 10.1111/ddg.14706] [Reference Citation Analysis]
10 Dippel E, Assaf C, Becker JC, von Bergwelt-Baildon M, Bernreiter S, Cozzio A, Eich HT, Elsayad K, Follmann M, Grabbe S, Hillen U, Klapper W, Klemke CD, Loquai C, Meiss F, Mitteldorf C, Wehkamp U, Nashan D, Nicolay JP, Oschlies I, Schlaak M, Stranzenbach R, Moritz R, Stoll C, Vag T, Weichenthal M, Wobser M, Stadler R. S2k-Leitlinie - Kutane Lymphome (ICD10 C82-C86): Update 2021. J Dtsch Dermatol Ges 2022;20:537-55. [PMID: 35446484 DOI: 10.1111/ddg.14706_g] [Reference Citation Analysis]